Oramed Pharmaceuticals Inc. (ORMP) vs Veraxa Biotech AG (VRXA)

Oramed Pharmaceuticals Inc. ORMP 4.07 −2.63%
Veraxa Biotech AG VRXA 1.11 +0.91%

Oramed Pharmaceuticals Inc. and Veraxa Biotech AG are both Biotechnology companies. Oramed Pharmaceuticals Inc. and Veraxa Biotech AG are of similar size ($173.9M and $162.5M).

Metric	ORMP	VRXA	Biotechnology median
P/E	0.96	—	8.50
P/S	41.54	—	9.71
P/B	0.53	—	2.13
Price to free cash flow	n/m	—	20.82
EV/EBITDA	n/m	—	0.64
EV/Sales	28.95	—	9.21
Earnings yield	103.93%	—	(33.15%)
Free cash flow yield	(3.12%)	—	(25.50%)

Metric	ORMP	VRXA	Biotechnology median
Gross margin	32.31%	—	65.16%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	73.90%	—	(56.36%)
Return on assets	65.52%	—	(48.04%)
Return on invested capital	(3.40%)	—	0.00%

Metric	ORMP	VRXA	Biotechnology median
Revenue growth (TTM)	347.77%	—	6.02%
EPS growth (last fiscal year)	412.50%	—	30.26%
Revenue growth, 5-year CAGR	(5.85%)	—	9.41%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	ORMP	VRXA	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	4.98	—	4.72
Net debt to EBITDA	8.41	—	0.96

Metric	ORMP	VRXA	Biotechnology median
Dividend yield	6.14%	—	0.09%
Payout ratio	0.06	—	—

Metric	ORMP	VRXA	Biotechnology median
Market cap	173.87m	162.50m	135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack